Literature DB >> 9646348

[Diagnosis of vesicoureteral reflux with echo-enhanced micturition urosonography].

K Darge1, T Dütting, B Zieger, K Möhring, W Rohrschneider, J Tröger.   

Abstract

AIM: To ascertain the diagnostic efficacy of reflux sonography with the application of the echo-enhancing agent Levovist in comparison with X-ray voiding cystourethrography (VCUG). PATIENTS AND METHODS: Echo-enhanced voiding urosonography (VUS) and VCUG were performed successively in one examination session in 114 children referred for the investigation of possible vesicoureteral reflux (VUR). After sonography of the urinary tract the bladder was filled with normal saline and Levovist was administered. Reflux was diagnosed when hyperechogenic, floating microbubbles appeared in the ureters or renal pelvises.
RESULTS: A total of 226 kidney-ureter units were available for analysis. Reflux was diagnosed in 80 units. All grades of reflux were represented. In 15 kidney-ureter units VUR was diagnosed with echo-enhanced VUS but was not seen at VCUG. The contrary was true in 3 units. High sensitivity and specificity in comparison to the VCUG could be attributed to the echo-enhanced VUS. The long imaging window attainable with Levovist makes the documentation of convincing images possible, contributing to the high diagnostic efficacy.
CONCLUSION: Echo-enhanced VUS is comparable to VCUG in the diagnosis of reflux.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646348     DOI: 10.1007/s001170050372

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  11 in total

Review 1.  [Advances in pediatric sonography].

Authors:  K Darge; M Beer
Journal:  Radiologe       Date:  2003-10       Impact factor: 0.635

2.  Voiding urosonography with second-generation contrast agent versus voiding cystourethrography.

Authors:  Eva Kis; Anna Nyitrai; Ildikó Várkonyi; István Máttyus; Orsolya Cseprekál; György Reusz; Attila Szabó
Journal:  Pediatr Nephrol       Date:  2010-08-05       Impact factor: 3.714

3.  [Modern ultrasound technologies and their application in pediatric urinary tract imaging].

Authors:  K Darge; A Heidemeier
Journal:  Radiologe       Date:  2005-12       Impact factor: 0.635

4.  Voiding urosonography with second-generation ultrasound contrast versus micturating cystourethrography in the diagnosis of vesicoureteric reflux.

Authors:  L S Wong; K S Tse; T W Fan; K Y Kwok; T K Tsang; H S Fung; W Chan; K W Lee; M W Y Leung; N S Y Chao; K W Tang; S C H Chan
Journal:  Eur J Pediatr       Date:  2014-08       Impact factor: 3.183

5.  Application of a second-generation US contrast agent in infants and children--a European questionnaire-based survey.

Authors:  Michael Riccabona
Journal:  Pediatr Radiol       Date:  2012-10-03

6.  Low contrast dose voiding urosonography in children with phase inversion imaging.

Authors:  Andrea Kopitzko; Daniel Cornely; Klaus Reither; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315

Review 7.  Voiding urosonography with US contrast agents for the diagnosis of vesicoureteric reflux in children. II. Comparison with radiological examinations.

Authors:  Kassa Darge
Journal:  Pediatr Radiol       Date:  2007-07-18

8.  Voiding urosonography as first step in the diagnosis of vesicoureteral reflux in children: a clinical experience.

Authors:  Mario Giordano; Rocco Marzolla; Flora Puteo; Lucio Scianaro; Domenica Angela Caringella; Tommaso Depalo
Journal:  Pediatr Radiol       Date:  2007-05-23

9.  Comparison of voiding cystourethrography and urosonography with second-generation contrast agents in simultaneous prospective study.

Authors:  Maciej Piskunowicz; Dominik Świętoń; Dorota Rybczyńska; Piotr Czarniak; Arkadiusz Szarmach; Mariusz Kaszubowski; Edyta Szurowska
Journal:  J Ultrason       Date:  2016-12-30

10.  Intravenous contrast-enhanced sonography in children and adolescents - a single center experience.

Authors:  Martin Stenzel
Journal:  J Ultrason       Date:  2013-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.